Schwetzingen, Germany

Uwe Haberkorn

This inventor holds 20 USPTO granted patents and 13 published patent applications, plus 4 CIPO patents and 11 EPO patents, primarily in Molecular Imaging. Top assignees: Deutsches Krebsforschungszentrum, Ruprecht-Karls-Universitat Heidelberg, Ruprecht-Karls-Universitaet Heidelberg. Active years: 2015-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Uwe Haberkorn. Retrieved from https://idiyas.com/inventor/uwe-haberkorn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 

% Patents Active = 90.0

 

 

Average Co-Inventor Count = 5.4

ph-index = 5

Forward Citations = 74(Granted Patents)


Location History:

  • Schweitzingen, DE (2019)
  • Schwetzingen, DE (2015 - 2024)

Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Molecular Imaging
Prostate Cancer
Peptide Conjugates
Cell-Penetrating Peptides
Liver Targeting
Imaging Agents
Hydrophobic Peptides
Cancer Treatment
Nephrotoxic Protection
Macromolecule Delivery
Cyclic Peptides
20 patents (USPTO):Explore Patents

Title: Uwe Haberkorn: A Visionary in the World of Patents and Inventions

Introduction:

Uwe Haberkorn, a renowned inventor based in Schwetzingen, Germany, has made significant contributions to the field of patents and inventions with his exceptional talent and unwavering passion for innovation. With 19 patents to his name, Haberkorn has cemented his reputation as a visionary in the realm of technological advancements.

Latest Patents:

Two of his latest patents showcase his expertise in the field of radiopharmaceuticals and molecular imaging. The first patent involves F-tagged inhibitors of prostate-specific membrane antigen (PSMA) for imaging agents in prostate cancer diagnosis. The second patent focuses on a double-labeled probe for molecular imaging, particularly for detecting neoplastic cells in vitro.

Career Highlights:

Throughout his career, Haberkorn has worked with esteemed organizations such as the German Cancer Research Center (Deutsches Krebsforschungszentrum) and the University of Heidelberg (Ruprecht-Karls-Universität Heidelberg). His innovative research and groundbreaking inventions have pushed the boundaries of what is possible in the field of nuclear medicine and molecular imaging.

Collaborations:

Haberkorn's collaborations with fellow experts in the field, including Walter Mier and Klaus Kopka, have led to the development of cutting-edge technologies and methodologies. Together, they have advanced the field of cancer imaging and diagnostics, paving the way for more accurate and efficient detection methods.

Conclusion:

Uwe Haberkorn's relentless pursuit of excellence, combined with his visionary approach to innovation, has not only elevated his own career but has also inspired a new generation of inventors to strive for greatness in the world of patents and inventions. His impact on the field of radiopharmaceuticals and molecular imaging will continue to shape the future of healthcare and diagnostics for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…